Loading...
Loading...
CSBR| Name | Value |
|---|---|
| Revenues | 12.6M |
| Cost of Revenue | 7.7M |
| Gross Profit | 4.9M |
| Operating Expense | 7.4M |
| Operating I/L | -2.6M |
| Other Income/Expense | 0.0M |
| Interest Income | 0.0M |
| Pretax | -2.5M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -2.6M |
Champions Oncology, Inc. specializes in developing and selling technology solutions and products to personalize the development and use of oncology drugs in the United States. Their Tumorgraft Technology Platform involves implanting human tumors in immune-deficient mice to personalize cancer care. Additionally, they offer Translational Oncology Solutions to aid pharmaceutical and biotechnology companies in their drug development process. The company also provides Lumin Bioinformatics, a software platform and data tool, available through annual subscriptions. Champions Oncology, Inc. markets its products through internet, word of mouth, and a dedicated sales force to patients and physicians.
